Exploring a new intervention approach for children with ASD and sleep disorders

The University of the Sunshine Coast, in collaboration with Brain Treatment Centre and Queen's Children Lungs and Sleep Specialist, is recruiting children (6-12 years old) diagnosed with Autism Spectrum Disorder (level 2) to participate in an interventional clinical trial.

Who can participate:

• children between 6-12 years old with a diagnosis of ASD (level 2) and reported sleep difficulties
• children who can undergo 2 to 4 sleep assessments using polysomnography (at-home sleep monitor) and actigraphy (wearable on the wrist)
• children who have never been treated with repetitive transcranial magnetic stimulation (rTMS) or EEG-tailored transcranial magnetic stimulation (α-rTMS) before.

For more information and expression of interest, click on the link below or contact Uchenna Ezedinma by email Uchenna.Ezedinma@research.usc.edu.au.

This research has been approved by the University of the Sunshine Coast's Ethics Committee (S221766) and registered under the Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12623000757617